This patient was treated with 10 days of oral cephalexin 500 mg, a Medrol® dosepak (methylprednisolone), and OTC hydrocortisone 1% cream. The rash was almost completely resolved within 3 days.

This is the first randomized controlled trial investigating the efficacy and safety of low-dose prolonged methylprednisolone administration in early ARDS. This study tested a pathophysiologic ...